Abstract
It is important for achieving complete remission of acute myelogenous leukemia to manage anemia and bone marrow hypoplasia, which cause serious complications. Anemia and bone marrow hypoplasia are mainly treated by supportive therapies consisting of granulocyte-colony stimulating factor, red blood cell transfusion and platelet transfusion, which are given according to recommendations of guidelines. In addition to these supportive therapies, new drugs such as DNA demethylating agents are developed for myelodysplastic syndrome (MDS). These drugs are expected to improve a cytopenia, and reduce the frequency of transfusions.
| Original language | English |
|---|---|
| Pages (from-to) | 1974-1977 |
| Number of pages | 4 |
| Journal | Nippon rinsho. Japanese journal of clinical medicine |
| Volume | 67 |
| Issue number | 10 |
| Publication status | Published - 2009 Oct |